PAVmed Interest Expense from 2010 to 2024

PAVMZ Stock  USD 0.01  0.0001  0.66%   
PAVmed Series Interest Expense yearly trend continues to be fairly stable with very little volatility. Interest Expense will likely drop to about 559.5 K in 2024. Interest Expense is the cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit. View All Fundamentals
 
Interest Expense  
First Reported
2017-09-30
Previous Quarter
11 K
Current Value
12 K
Quarterly Volatility
492.3 K
 
Covid
Check PAVmed Series financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PAVmed Series' main balance sheet or income statement drivers, such as Interest Expense of 559.5 K, Selling General Administrative of 32.5 M or Other Operating Expenses of 74.8 M, as well as many indicators such as Price To Sales Ratio of 11.54, Dividend Yield of 3.0E-4 or Days Sales Outstanding of 14.05. PAVmed financial statements analysis is a perfect complement when working with PAVmed Series Valuation or Volatility modules.
  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Latest PAVmed Series' Interest Expense Growth Pattern

Below is the plot of the Interest Expense of PAVmed Series Z over the last few years. It is the cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit. PAVmed Series' Interest Expense historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in PAVmed Series' overall financial position and show how it may be relating to other accounts over time.
Interest Expense10 Years Trend
Slightly volatile
   Interest Expense   
       Timeline  

PAVmed Interest Expense Regression Statistics

Arithmetic Mean760,157
Geometric Mean0.00
Coefficient Of Variation202.77
Mean Deviation955,064
Median32,667
Standard Deviation1,541,338
Sample Variance2.4T
Range5.8M
R-Value0.41
Mean Square Error2.1T
R-Squared0.17
Significance0.13
Slope141,227
Total Sum of Squares33.3T

PAVmed Interest Expense History

2024559.5 K
2023589 K
20221.3 M
20215.8 M
202053 K
201932.7 K
20182.4 M

About PAVmed Series Financial Statements

PAVmed Series investors use historical fundamental indicators, such as PAVmed Series' Interest Expense, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in PAVmed Series. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Interest Expense589 K559.5 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for PAVmed Stock Analysis

When running PAVmed Series' price analysis, check to measure PAVmed Series' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PAVmed Series is operating at the current time. Most of PAVmed Series' value examination focuses on studying past and present price action to predict the probability of PAVmed Series' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PAVmed Series' price. Additionally, you may evaluate how the addition of PAVmed Series to your portfolios can decrease your overall portfolio volatility.